Clinical insight
Begin with a clearly defined patient population, an unmet need and an outcome that matters.
A biotechnology company with roots in scientific translation and a focus on therapies for unmet clinical needs.
Founded in 2018, LotusLake Biomedical is based in Beijing and operates the Cell and Gene Therapy Innovation Center (CGTIC).
The company was initiated under the guidance of the Beijing Tsinghua Industrial R&D Institute. Our work has evolved from bioinformatics and engineering services toward the development of innovative therapeutic products.
Today, we focus on Engineered Biological Payload Therapeutics: integrating clinical insight, AI-assisted target evaluation, biological engineering and translational development.
We aim to extend human healthspan by developing therapies that address disease, preserve function and respond to meaningful clinical needs.


Company established, building on bioinformatics, target research and synthetic biology.
Process development, quality systems and a manufacturing platform for nucleic acids and gene delivery.
Closer engagement with clinicians and research institutions to define unmet needs and translational opportunities.
A stronger focus on EBPT programs, AI-assisted validation, product-specific evidence and international partnering.
Begin with a clearly defined patient population, an unmet need and an outcome that matters.
Turn biological hypotheses into testable questions and distinguish predictions from experimental findings.
Connect product design to process control, repeatable measurements and development decisions.


Interested in working at the intersection of biology, computation and translation?
Connect with our teamBring a clinical challenge, a scientific discovery or a development ambition. Let’s explore what we can build together.
Start a conversation